SCHEMBL4057138

SCHEMBL4057138

Cc1cnccc1CC=O

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SIRT3 Q9NTG7 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ AOC1 P19801 4/20 0.35
▸ AOC3 Q16853 4/20 0.35
▸ GPR119 Q8TDV5 1/20 0.34
▸ LOXL2 Q9Y4K0 1/20 0.34
▸ CYP2E1 P05181 1/20 0.34
▸ CYP2C8 P10632 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2A6 P11509 1/20 0.34
▸ CYP2B6 P20813 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ HTT P42858 1/20 0.33
▸ BUB1 O43683 1/20 0.33
▸ TRPA1 O75762 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3976911 0.84 SIRT3 (0.40) SIRT3TDP1AOC1AOC3CYP2E1
SCHEMBL30753498 0.81 ADAMTS4 (0.34) SIRT3TDP1AOC1AOC3GPR119
SCHEMBL16671024 0.80 CYP2E1 (0.41) AOC1AOC3LOXL2CYP2E1CYP2C8
SCHEMBL214076 0.79 — —
SCHEMBL3914203 0.76 GAA (0.42) AOC1AOC3LOXL2CYP2E1CYP2C8
SCHEMBL4051088 0.76 PARP1 (0.39) AOC1AOC3LOXL2CYP2E1CYP2C8
SCHEMBL459713 0.76 LOXL2 (0.57) AOC1AOC3GPR119LOXL2CYP2E1
SCHEMBL16702897 0.76 AOC1 (0.59) TDP1AOC1AOC3LOXL2CYP2E1
SCHEMBL3647173 0.76 ERN1 (0.40) TDP1AOC1AOC3LOXL2CYP2E1
SCHEMBL459319 0.76 CA12 (0.41) GPR119CYP2E1CYP2D6CYP2A6CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2736330-A1 COMPOUNDS AND METHODS Tempero Pharmaceuticals, Inc. (US) 2014-06-04 — — EP disclosed
WO-2013019626-A1 COMPOUNDS AND METHODS TEMPERO PHARMACEUTICALS, INC. (US) 2013-02-07 — — WO disclosed
WO-2013019682-A1 COMPOUNDS AND METHODS TEMPERO PHARMACEUTICALS, INC. (US) 2013-02-07 — — WO disclosed
WO-2009114552-A1 HETEROARYL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE IN CANCER TREATMENT THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2009-09-17 — — WO disclosed
Send feedback